{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-053463","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.012073+00:00","generated_at":"2026-05-19T13:56:42.965735+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"CEO and CMO waive 2023 and 2024 bonuses to reduce liabilities","bullets":["CEO Eric Schlorff and CMO Dr. Kevin Chung agreed to waive earned bonuses for 2023 and 2024 fiscal years.","Bonus release agreements aim to reduce company liabilities; consideration is continued employment at current pay.","Agreements include a release of claims against the company for compensation-related matters.","Dollar amount of waived bonuses is not disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-053463","json":"https://secwatch.observer/filing/0001213900-25-053463.json","markdown":"https://secwatch.observer/filing/0001213900-25-053463.md","text":"https://secwatch.observer/filing/0001213900-25-053463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000121390025053463/0001213900-25-053463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000121390025053463/ea0245443-8k_seastar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:56:42.965735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}